Thisis a harvest season.

XIAMEN SPACEGEN CO.,LTD., an intensive cultivation company in the field of medical precisionservices receives good news frequently.

Recently, Spacegen participatedin a quality evaluation organized by Clinical Laboratory Center (NCCL) from theNational Health Commission. The evaluation is a new round of the "2021National Novel Coronavirus Variant Nucleic Acid Testing Laboratory QualityEvaluation Survey".Theevaluation results showed that Spacegen Medical Laboratory has passed multipleNCCL quality evaluations with full score that all test results are 100%consistent with expected results, which has once again proved its perfectquality management system and excellent testing ability.

▲Figure 1 

▲Figure 2

Nucleic acid testing isan important method for the diagnosis of novel coronavirus pneumonia. Theexternal quality evaluation of the novel coronavirus nucleic acid testing organizedby NCCL aims to help clinical laboratories find problems in testing and makeimprovements, so that nucleic acid testing can be better used in diseaseprevention and control.

The development of the novelcoronavirus is unpredictable, disrupting social /economic development andpeople's daily life. Therefore, strict and careful testing capabilities are thekeys to ensure the safety of human life. As a precision detection servicecompany, Spacegen will continue to provide good novel coronavirus detectionservices, will continue to actively respond actively and fully cooperate withthe national nucleic acid detection work. Currently the company’s detectionservices cover the city cultural and tourism systems, industry and informatic systems,market supervision and management systems, urban construction systems,education systems, pensions. System, Commerce Bureau, Civil Affairs Bureau aswell as other bureaus and industries.